KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Samira Sakhia on Q1 2022 Results - Earnings Call Transcript
Knight Therapeutics Inc. (KHTRF) Q1 2022 Earnings Conference Call May 12, 2022, 08:30 AM ET Company Participants Samira Sakhia - President and CEO Amal Khouri - Chief Business Officer Arvind Utchanah - CFO Jeff Martens - Global VP, Commercial Conference Call Participants Doug Miehm - RBC Capital Markets Endri Leno - National Bank Justin Keywood - Stifel GMP Scott McAuley - Paradigm Capital Rahul Sarugaser - Raymond James David Martin - Bloom Burton Presentation Operator Good morning, ladies and gentlemen. My name is Chad, and I'll be your operator today. Welcome to Knight Therapeutics Inc. First Quarter 2022 Results Conference Call. Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may by their nature necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The company considers the
For further details see:
Knight Therapeutics Inc. (KHTRF) CEO Samira Sakhia on Q1 2022 Results - Earnings Call Transcript